Our source library
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx: current advertised treatments and pricesProvider starting prices; final plan and billing terms require confirmation
- CoreAge Rx Help Center: current product catalogProvider formulation and consultation information
- Ro: weight-loss careProvider care model and current medication menu
- Ro: membership and medication pricingSeparate charges, prepayment periods and dose-specific offers
- Ro: Wegovy accessProvider access information, not independent clinical evidence
- Ro: Zepbound accessProvider product access and care terms
- Hers: weight-loss membershipMembership fee and medicine costs are separate
- Hers: Wegovy pillCurrent product page and starting medication quote
- Hers: Zepbound KwikPenProduct format, membership requirement and cancellation explanation
- Mochi Health: current care modelProvider membership and care overview
- Mochi: compounded semaglutideStarting medication quote; dose-dependent; membership extra
- Mochi: compounded tirzepatideStarting medication quote; dose-dependent; membership extra
- LillyDirect: Zepbound formats and pricesManufacturer fulfillment and self-pay program terms
- Lilly: Zepbound savings termsFormat-specific prices, eligibility and refill-window conditions
- Zepbound prescribing informationManufacturer prescribing information, warnings and approved uses
- Wegovy prescribing informationManufacturer labeling; formulation-specific directions and safety information
- FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags
- NIDDK: prescription medicines for overweight and obesityEligibility, long-term care, treatment context and insurance questions